A new era in moderate- to- severe Atopic Dermatitis : Using Abrocitinb to get patients on the Right track
In this webinar, a detailed discussion is done on a new era in moderate- to- severe Atopic Dermatitis : Using Abrocitinb to get patients on the Right
Speakers : Dr. Sandipan Dhar ,Dr. Shireen Furtado ,Dr. Ramesh Bhat ,Dr. Debjit Kar ,Dr. Maitreyee Panda
New advances in the management of Atopic dermatitis & role of PDE4 Inhibitor
In this webinar, a detailed discussion is done through the interesting session on the new advances in the management of atopic dermatitis.
Speakers : Dr. Anup Kumar Lahiry ,Dr. Rajetha Damisetty ,Dr. Raghavendra Rao ,Dr. V Anand Kumar ,Dr. C Brijesh Nair
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Adult overdose deaths on the rise
2.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
3.
To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.
4.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
5.
New study links air pollution with higher rates of head and neck cancer
1.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
2.
Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring
3.
The Importance of Maintaining Normal Calcium Levels in Your Body
4.
The Truth About Marijuana and Its Effect on Mental Health
5.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge